Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Genetic determinants of low high-density lipoprotein cholesterol.

Miller M, Zhan M.

Curr Opin Cardiol. 2004 Jul;19(4):380-4. Review.

PMID:
15218400
2.

High density lipoprotein and coronary heart disease: insights from mutations leading to low high density lipoprotein.

Calabresi L, Franceschini G.

Curr Opin Lipidol. 1997 Aug;8(4):219-24. Review.

PMID:
9253538
3.

Genes associated with low serum high-density lipoprotein cholesterol.

Ahmadzadeh A, Azizi F.

Arch Iran Med. 2014 Jun;17(6):444-50. doi: 014176/AIM.0013. Review.

4.

Genetic factors affecting HDL levels, structure, metabolism and function.

Sviridov D, Nestel PJ.

Curr Opin Lipidol. 2007 Apr;18(2):157-63. Review.

PMID:
17353664
5.
6.

High density lipoproteins and coronary heart disease. Future prospects in gene therapy.

Fruchart JC, Duriez P.

Biochimie. 1998 Feb;80(2):167-72. Review.

PMID:
9587674
7.

High-density lipoprotein metabolism, composition, function, and deficiency.

Schaefer EJ, Anthanont P, Asztalos BF.

Curr Opin Lipidol. 2014 Jun;25(3):194-9. doi: 10.1097/MOL.0000000000000074. Review.

PMID:
24785961
8.

Genetics of HDL regulation in humans.

Miller M, Rhyne J, Hamlette S, Birnbaum J, Rodriguez A.

Curr Opin Lipidol. 2003 Jun;14(3):273-9. Review.

PMID:
12840658
9.

Probing the pathways of chylomicron and HDL metabolism using adenovirus-mediated gene transfer.

Zannis VI, Chroni A, Kypreos KE, Kan HY, Cesar TB, Zanni EE, Kardassis D.

Curr Opin Lipidol. 2004 Apr;15(2):151-66. Review.

PMID:
15017358
10.

Familial hypoalphalipoproteinemias.

Frohlich J, Westerlund J, Sparks D, Pritchard PH.

Clin Invest Med. 1990 Aug;13(4):202-10. Review.

PMID:
2119926
11.

ABC1: the gene for Tangier disease and beyond.

Ordovas JM.

Nutr Rev. 2000 Mar;58(3 Pt 1):76-9. Review.

PMID:
10812922
12.

Genetic determinants of HDL: monogenic disorders and contributions to variation.

Klos KL, Kullo IJ.

Curr Opin Cardiol. 2007 Jul;22(4):344-51. Review.

PMID:
17556888
13.

[The role of transmembrane lipidtransporter molecules in the atherosclerotic process].

Harangi M, Köbling T, Paragh G.

Orv Hetil. 2006 Feb 12;147(6):251-7. Review. Hungarian.

PMID:
16610615
14.

Cholesterol efflux regulatory protein, Tangier disease and familial high-density lipoprotein deficiency.

Hayden MR, Clee SM, Brooks-Wilson A, Genest J Jr, Attie A, Kastelein JJ.

Curr Opin Lipidol. 2000 Apr;11(2):117-22. Review.

PMID:
10787172
15.

Role of fibric acid derivatives in the management of risk factors for coronary heart disease.

Després JP, Lemieux I, Robins SJ.

Drugs. 2004;64(19):2177-98. Review.

PMID:
15456334
16.

High density lipoprotein, apolipoprotein A-I, and coronary artery disease.

Srivastava RA, Srivastava N.

Mol Cell Biochem. 2000 Jun;209(1-2):131-44. Review.

PMID:
10942211
17.

Tangier disease four decades of research: a reflection of the importance of HDL.

Kolovou GD, Mikhailidis DP, Anagnostopoulou KK, Daskalopoulou SS, Cokkinos DV.

Curr Med Chem. 2006;13(7):771-82. Review.

PMID:
16611066
18.
19.

Hypoalphalipoproteinemia (low high density lipoprotein) as a risk factor for coronary heart disease.

Vega GL, Grundy SM.

Curr Opin Lipidol. 1996 Aug;7(4):209-16. Review.

PMID:
8883496
20.

Unravelling high density lipoprotein-apolipoprotein metabolism in human mutants and animal models.

Rader DJ, Ikewaki K.

Curr Opin Lipidol. 1996 Jun;7(3):117-23. Review.

PMID:
8818507

Supplemental Content

Support Center